Publications and Conference Abstracts : bDMARDs

Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2021 Virtual, 4-12 September 2021

(2021), IBD Clinical. Journal of Gastroenterology and Hepatology, 36: 91 132. https://doi.org/10.1111/jgh.15613

Sheppard J, Rowett D, O’Connor D, Bridges L, Dartnell J, Pulver L, Begun J, Connor S, Massuger W, Brown S, Ye J. Designing a national education program to support quality use of medicines for patients with inflammatory bowel disease

Australian Rheumatology Association 61st Annual Scientific Meeting, 21–23 May 2021

 ARA 2021 Abstracts. Intern Med J, 51: 5-52. https://doi.org/10.1111/imj.15302 

Sidhu N, Marine F, Lester S, Quinlivan A, Rowett D, Buchbinder R, Hill C. Comparison of rheumatology and gastroenterology patient perceptions towards biologic and biosimilar therapy

Lyon A, Quinlivan A, Lester S, Barrett C, Whittle S, Marine F, Rowett D, Black R, Sinnathurai P, March L, Buchbinder R, Hill C. Vaccination rates, perceptions and information sources utilised by Australian patients with inflammatory arthritis

Quinlivan A, Lester S, Barrett C, Whittle S, Rowett D, Black R, Chand V, Marine F, March L, Sinnathurai P, Buchbinder R, Hill C. Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars

Sheppard J, Dartnell J, Granger R, Sinnathurai P, Buchbinder R, Hill C, Barrett C, Marine F, Whittle S, Donnelly J, Jackson S, Rowett D, Hayward K. Initiating a national consortium approach to support optimal use of bDMARDs

Ye J, Marson A, Sinnathurai P, Pulver L, Barrett C, Hill C, Rowett D, O’Connor D, Sheppard J, Dartnell J. Patterns of use of b/tsDMARDs and other medications for patients with rheumatoid arthritis: a retrospective study using PBS data

Hains I, Sinnathurai P, Hill C, Barrett C, Pulver L, Rudd T, Rowett D, Sheppard J. What do rheumatologists think and do in the management of inflammatory arthritis: a baseline survey

National Medicines Symposium 2021, 18 May 2021

https://www.nps.org.au/assets/NMS-2021-abstracts.pdf

Pulver L, Donnelly J, Bradbury L, Ciabotti L, Du Q, O’Neill S, Rentsch C, Yik J. Supporting safe practices for low-dose methotrexate

Ye J, Marson A, Sinnathurai P, Pulver L, Barrett C, Hill C, Rowett D, O’Connor D, Sheppard J, Dartnell J. Patterns of use of b/tsDMARDs and other medicines for patients with rheumatoid arthritis: a retrospective study using PBS data

National Medicines Symposium 2020, 7 December 2020

Elliot J, Dartnell J, Granger R, Buchbinder R, Hill C, Barrett C, Marine F, Whittle S, Etherton-Beer C, Jackson S, Rowett D, de Wever J. Initiating a national consortium approach to support optimal use of bDMARDs  

Australian Rheumatology Association 60th Annual Scientific Meeting, 16‐19 May 2020

ARA 2020 Abstracts. Intern Med J, 50: 5-52. https://doi.org/10.1111/imj.14932

Lalor A, Brooker J, Rozbroj T, Whittle S, Hill C, Rowett D, O’Connor D, Buchbinder R. Clinician perspectives factors influencing prescribing and use of disease modifying anti-rheumatic drugs in inflammatory rheumatic disorders from the perspectives of clinicians: a qualitative evidence synthesis

Whittle S, Hill C, Buchbinder R. Member survey to identify priority questions for a living guideline for the pharmacological management of rheumatoid arthritis

Dartnell J, Elliot J, Buchbinder R, Hill C, Barrett C, Marine F, Whittle S, Etherton-Beer C, Jackson S, Rowett D, de Wever J. Developing a collaborative national program to optimise use of bDMARDs